Lyell Immunopharma (LYEL) Revenue (2020 - 2026)
Lyell Immunopharma (LYEL) reported Revenue of $2000.0 for Q1 2026, down 71.43% on a YoY basis from $7000.0 in Q1 2025, and down 66.67% sequentially from $6000.0 in Q4 2025.
Lyell Immunopharma (LYEL) Revenue (2020 - 2026) Analysis & Trends
Lyell Immunopharma (LYEL) has 7 years of Revenue data on file, last reported at $2000.0 in Q1 2026.
- For the quarter ending Q1 2026, Revenue fell 71.43% year-over-year to $2000.0; the trailing twelve-month figure through Mar 2026 stood at $31000.0 (down 52.31% YoY), and the FY2025 full-year result was $36000.0, down 40.98% from the prior year.
- Revenue fell to $2000.0 in Q1 2026, from $6000.0 in the prior quarter.
- In the past five years, Revenue ranged from a high of $48.4 million in Q4 2022 to a low of $2000.0 in Q1 2026.
- A 5-year average of $5.0 million and a median of $13000.0 in 2023 frame the typical range for Revenue.
- Across the five-year window, Revenue jumped 1614.6% in 2022 and sank 99.97% in 2023, its largest moves.
- Tracing LYEL's Revenue over 5 years: stood at $48.4 million in 2022, then slumped by 99.97% to $13000.0 in 2023, then declined by 15.38% to $11000.0 in 2024, then slumped by 45.45% to $6000.0 in 2025, then tumbled by 66.67% to $2000.0 in 2026.
- Business Quant data shows LYEL's Revenue at $2000.0 in Q1 2026, $6000.0 in Q4 2025, and $15000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 1.51 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 2.99 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 3.61 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 1.56 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Lyell Immunopharma | 298.14 Mn | 298.14 Mn | - | 2,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2,000.00 |
| Dec 31, 2025 | 6,000.00 |
| Sep 30, 2025 | 15,000.00 |
| Jun 30, 2025 | 8,000.00 |
| Mar 31, 2025 | 7,000.00 |
| Dec 31, 2024 | 11,000.00 |
| Sep 30, 2024 | 34,000.00 |
| Jun 30, 2024 | 13,000.00 |
| Mar 31, 2024 | 3,000.00 |
| Dec 31, 2023 | 13,000.00 |
| Sep 30, 2023 | 25,000.00 |
| Jun 30, 2023 | 27,000.00 |
| Mar 31, 2023 | 65,000.00 |
| Dec 31, 2022 | 48.39 Mn |
| Sep 30, 2022 | 3,000.00 |
| Jun 30, 2022 | 35.74 Mn |
| Mar 31, 2022 | 553,000.00 |
| Dec 31, 2021 | 2.82 Mn |
| Sep 30, 2021 | 2.76 Mn |
| Jun 30, 2021 | 2.63 Mn |